Thalassaemia International Federation


Conference 4th International Conference on Blood Malignancies & Treatment:

Blood Cancer 2016 will be an initiative to find the weapon to fight against the dreadful blood cancers, to protect and save lives. Discussions will be focused on the different types of blood cancers, possibility of early detection and treatment at the advanced stages of these cancers to prolong life. The conference will be organized around the theme “Conquering blood cancer with contemporary precision therapeutics and restorative approaches”.

And along with its subsidiary which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

Blood cancer is a type of cancer or tumor. Blood cancer affects the blood, bone marrow, lymph, and lymphatic system, sometimes more than one body part gets affected. It affects the production and function of your blood cells. Most of these cancers start in your bone marrow where blood is produced. The most common types of blood cancers are Leukemia, Lymphoma, Myeloma and Myelodysplastic Syndrome.

Billions of people are suffering from blood cancers and millions are dying every year across the globe. Blood cancer affects a large number of people. Every 20 minutes, one person in UK is detected with blood cancer, 70 people a day, and 25,000 people a year. According to the CDC, cancer is the second leading cause of mortality, causing 584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms such as next-generation sequencing, DNA microarrays, and polymerase chain reaction (PCR). Moreover, the market has seen the advent of hybrid imaging instruments with enhanced accuracy, such as PET/CT and SPECT/CT. These advancements have augmented the growth of the cancer diagnostics market. The global cancer diagnostics market is expected to reach $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, growing at a CAGR of 12.9%. The global tumor ablation market is poised to grow at a CAGR of 11.5% during 2014-2019, and is expected to reach a value of 462.0 Million in 2019.

Target Audience :

  • Hematologists
  • Oncologists
  • Immunologists
  • Pathologists
  • Hemopathologists
  • Radiologists
  • Academicians
  • Research Scholars
  • Students
  • Hematology Associations & Societies
  • Business Entrepreneurs
  • Software Developing Companies
  • Medical Devices Companies
  • Biomedical Companies
  • Biotechnology Companies
  • Data Management Companies

Collaborated Conference:

3rd International Conference on Hematology & Blood Disorders

Date: November 02-04, 2015

Venue: Atlanta, USA

Short Name: Hematology-2016

International Conference on Hematology and Oncology

Date: June 29- July 1, 2017

Venue: Bangkok, Thailand

Short Name: Hematology and Oncology 2017

11th International Conference on Hematology & Hematological Oncology

Date: November 08-09, 2017

Venue: Las Vegas, Nevada, USA

Short Name: Hematology 2017

12th World Hematologists Congress

Date: March 15-16, 2018

Venue: London, UK

Short Name: Hematologists 2018

7th World Hematologists Congress

Date: May 08-09, 2017

Venue: Barcelona, Spain

Short Name: Hematologists 2017